Rowlett James K, Platt Donna M, Spealman Roger D
Harvard Medical School, New England Primate Research Center, Southborough, Massachusetts 01772-9102, USA.
J Pharmacol Exp Ther. 2004 Jul;310(1):342-8. doi: 10.1124/jpet.104.065631. Epub 2004 Feb 25.
In previous studies, heroin was shown to engender cocaine-like discriminative stimulus (DS) effects; however, the mechanisms underlying the cocaine-like effects of heroin are unknown. The present study evaluated the extent to which the shared DS effects of heroin and cocaine involve common monoaminergic mechanisms of action. In squirrel monkeys discriminating cocaine (0.3 mg/kg) from saline, heroin engendered full or partial substitution for cocaine in three of four monkeys. Pretreatment with the selective dopamine transport inhibitor 1-(2-[bis(4-fluorophenyl)methoxy]ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909) dose dependently enhanced the cocaine-like DS effects of heroin in these three monkeys as well as the DS effects of cocaine in all subjects. Neither talsupram, a noradrenergic transport inhibitor, nor prazosin, a noradrenergic antagonist selective for alpha-1 receptors, systematically altered the cocaine-like DS effects of heroin at doses that enhanced (talsupram) or attenuated (prazosin) the DS effects of cocaine. Pretreatment with the serotonin uptake inhibitor citalopram similarly failed to alter the cocaine-like DS effects of heroin at doses that attenuated the DS effects of cocaine. Altogether, these findings suggest that heroin shares DS effects with cocaine in a subset of monkeys, and these cocaine-like effects are mediated at least in part by enhanced dopaminergic activity. Unlike the DS effects of cocaine itself, however, the cocaine-like DS effects of heroin do not appear to involve either noradrenergic or serotonergic mechanisms.
在先前的研究中,已表明海洛因会产生类似可卡因的辨别性刺激(DS)效应;然而,海洛因产生类似可卡因效应的潜在机制尚不清楚。本研究评估了海洛因和可卡因共有的DS效应在多大程度上涉及共同的单胺能作用机制。在松鼠猴辨别可卡因(0.3毫克/千克)和生理盐水的实验中,四只猴子中有三只猴子出现海洛因完全或部分替代可卡因的情况。用选择性多巴胺转运抑制剂1-(2-[双(4-氟苯基)甲氧基]乙基)-4-(3-苯基丙基)哌嗪(GBR 12909)进行预处理,剂量依赖性地增强了这三只猴子中海洛因的类似可卡因的DS效应以及所有受试动物中可卡因的DS效应。去甲肾上腺素能转运抑制剂他索普明和α-1受体选择性去甲肾上腺素能拮抗剂哌唑嗪,在增强(他索普明)或减弱(哌唑嗪)可卡因DS效应的剂量下,均未系统性地改变海洛因的类似可卡因的DS效应。用5-羟色胺摄取抑制剂西酞普兰进行预处理,在减弱可卡因DS效应的剂量下,同样未能改变海洛因的类似可卡因的DS效应。总之,这些发现表明,在一部分猴子中,海洛因与可卡因具有共同的DS效应,且这些类似可卡因的效应至少部分是由增强的多巴胺能活性介导的。然而,与可卡因本身的DS效应不同,海洛因的类似可卡因的DS效应似乎不涉及去甲肾上腺素能或5-羟色胺能机制。